In January 2002, Genomica was acquired by Exelixis, Inc. For reasons not quite clear, while retaining a full license for theirown use, Exelixis sold on Genomica only three months later at a major loss to Vizualize. A pharmacogenomics software company, Genomica was founded to commercialize bioinformatics tools developed by Dr. Thomas G. Marr and his team at Cold Spring Harbor Laboratory in New York, Genomica's tools combine clinical, epidemiology, genetic, molecular biology, and biochemistry applications into a single software environment that enables scientists to accelerate genetic discoveries and pharmacogenomics. Genomica's software is used in the gene discovery process to develop custom drug applications and accelerate time to market for new drugs. The software supports a range of research activities and provides data that can be accessed and used by pharmaceutical and biotechnology companies.
